Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
Back to Home
H

HALO

Nasdaq

HALOZYME THERAPEUTICS, INC.

Latest disclosureOctober 2, 2026
Insider score Why 0?
0/ 100
Qualifying buys · 30d
$0

0 purchases · 61 sales

Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.

Insider transactions 122

Limited filing history
All122Buying0Selling61Other61
Filters

Last 30 daysNo qualifying insider buying. Sales: $9.05M by 2 insiders.

61 of 122 trades · April 1, 2026 – October 1, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.

Showing the first 6 of 61 trades on this page.

Sale disclosed

Matthew L. Posard

Director

Common Stock

Reported value
$78.23K
Reported price
$107.168 / share
Traded October 1, 2026Filed October 2, 2026SEC filing
Sale disclosed

Matthew L. Posard

Director

Common Stock

Reported value
$357.9K
Reported price
$108.454 / share
Traded October 1, 2026Filed October 2, 2026SEC filing
Sale disclosed

Matthew L. Posard

Director

Common Stock

Reported value
$120.53K
Reported price
$109.569 / share
Traded October 1, 2026Filed October 2, 2026SEC filing
Sale disclosed

Matthew L. Posard

Director

Common Stock

Reported value
$11K
Reported price
$110.04 / share
Traded October 1, 2026Filed October 2, 2026SEC filing
Sale disclosed

Matthew L. Posard

Director

Common Stock

Reported value
$329.01K
Reported price
$106.132 / share
Traded September 16, 2026Filed September 17, 2026SEC filing
Sale disclosed

Matthew L. Posard

Director

Common Stock

Reported value
$320.48K
Reported price
$106.828 / share
Traded September 16, 2026Filed September 17, 2026SEC filing
Sale disclosed

Matthew L. Posard

Director

Common Stock

Reported value
$961.12K
Reported price
$108.04 / share
Traded September 16, 2026Filed September 17, 2026SEC filing
Sale disclosed

Matthew L. Posard

Director

Common Stock

Reported value
$435.96K
Reported price
$108.991 / share
Traded September 16, 2026Filed September 17, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$1.43M
Reported price
$107.222 / share
Traded September 9, 2026Filed September 11, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$711.19K
Reported price
$107.821 / share
Traded September 9, 2026Filed September 11, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$10.87K
Reported price
$108.67 / share
Traded September 9, 2026Filed September 11, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$1.56M
Reported price
$107.012 / share
Traded September 10, 2026Filed September 11, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$582.23K
Reported price
$107.581 / share
Traded September 10, 2026Filed September 11, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$1.66M
Reported price
$107.154 / share
Traded September 11, 2026Filed September 11, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$484.83K
Reported price
$107.548 / share
Traded September 11, 2026Filed September 11, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$89.06K
Reported price
$98.958 / share
Traded August 17, 2026Filed August 19, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$50.23K
Reported price
$100.457 / share
Traded August 17, 2026Filed August 19, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$213.71K
Reported price
$101.766 / share
Traded August 17, 2026Filed August 19, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$922.98K
Reported price
$102.553 / share
Traded August 17, 2026Filed August 19, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$776.12K
Reported price
$103.482 / share
Traded August 17, 2026Filed August 19, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$587.88K
Reported price
$103.083 / share
Traded August 18, 2026Filed August 19, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$509.83K
Reported price
$104.11 / share
Traded August 18, 2026Filed August 19, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$985.82K
Reported price
$104.874 / share
Traded August 18, 2026Filed August 19, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$765.78K
Reported price
$106.358 / share
Traded August 19, 2026Filed August 19, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$1.03M
Reported price
$107.224 / share
Traded August 19, 2026Filed August 19, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$344.85K
Reported price
$107.765 / share
Traded August 19, 2026Filed August 19, 2026SEC filing
Sale disclosed

Bernadette Connaughton

Director

Common Stock

Reported value
$167.15K
Reported price
$102.80 / share
Traded August 10, 2026Filed August 11, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$70.4K
Reported price
$79.276 / share
Traded July 8, 2026Filed July 9, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$82.99K
Reported price
$80.187 / share
Traded July 8, 2026Filed July 9, 2026SEC filing
Sale disclosed

Bernadette Connaughton

Director

Common Stock

Reported value
$76.4K
Reported price
$76.395 / share
Traded July 1, 2026Filed July 2, 2026SEC filing
Sale disclosed

Bernadette Connaughton

Director

Common Stock

Reported value
$48.26K
Reported price
$77.209 / share
Traded July 1, 2026Filed July 2, 2026SEC filing
Sale disclosed

Mahesh Krishnan

Director

Common Stock

Reported value
$547.8K
Reported price
$75.00 / share
Traded June 29, 2026Filed June 30, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$106.88K
Reported price
$66.388 / share
Traded June 1, 2026Filed June 3, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$875.59K
Reported price
$67.41 / share
Traded June 1, 2026Filed June 3, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$369.14K
Reported price
$68.346 / share
Traded June 1, 2026Filed June 3, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$1.1M
Reported price
$66.314 / share
Traded June 2, 2026Filed June 3, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$226.93K
Reported price
$66.745 / share
Traded June 2, 2026Filed June 3, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$26.55K
Reported price
$66.368 / share
Traded June 3, 2026Filed June 3, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$101.51K
Reported price
$67.675 / share
Traded June 3, 2026Filed June 3, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$137.47K
Reported price
$68.736 / share
Traded June 3, 2026Filed June 3, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$425.12K
Reported price
$69.692 / share
Traded June 3, 2026Filed June 3, 2026SEC filing
Sale disclosed

Bernadette Connaughton

Director

Common Stock

Reported value
$107.59K
Reported price
$66.21 / share
Traded June 1, 2026Filed June 2, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$628.54K
Reported price
$64.631 / share
Traded May 11, 2026Filed May 13, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$234.01K
Reported price
$65.458 / share
Traded May 11, 2026Filed May 13, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$444.39K
Reported price
$66.327 / share
Traded May 11, 2026Filed May 13, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$6.79K
Reported price
$67.85 / share
Traded May 12, 2026Filed May 13, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$98.26K
Reported price
$70.287 / share
Traded May 12, 2026Filed May 13, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$699.57K
Reported price
$71.37 / share
Traded May 12, 2026Filed May 13, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$425.67K
Reported price
$72.148 / share
Traded May 12, 2026Filed May 13, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$204.74K
Reported price
$73.121 / share
Traded May 12, 2026Filed May 13, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$143.01K
Reported price
$68.102 / share
Traded May 13, 2026Filed May 13, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$230.75K
Reported price
$68.88 / share
Traded May 13, 2026Filed May 13, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$275.66K
Reported price
$69.787 / share
Traded May 13, 2026Filed May 13, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$42.49K
Reported price
$70.812 / share
Traded May 13, 2026Filed May 13, 2026SEC filing
Sale disclosed

Bernadette Connaughton

Director

Common Stock

Reported value
$103.16K
Reported price
$63.48 / share
Traded May 1, 2026Filed May 5, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$372.52K
Reported price
$63.139 / share
Traded April 6, 2026Filed April 7, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$262.46K
Reported price
$64.015 / share
Traded April 6, 2026Filed April 7, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$1.24M
Reported price
$65.358 / share
Traded April 1, 2026Filed April 2, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$65.71K
Reported price
$65.714 / share
Traded April 1, 2026Filed April 2, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$1.01M
Reported price
$64.063 / share
Traded April 2, 2026Filed April 2, 2026SEC filing
Sale disclosed

Helen Torley

PRESIDENT AND CEO

Common Stock

Reported value
$272.53K
Reported price
$64.887 / share
Traded April 2, 2026Filed April 2, 2026SEC filing
Reporting insiderSecurity / transactionAmount / priceValueTraded / disclosedSource
DirectorCommon StockSale10b5-14 trades5,230avg $108.54 / share$567.66KOct 1Filed Oct 2 · 1d later
4 filings
  • 730 @ $107.17 · $78.23KSEC filing
  • 3,300 @ $108.45 · $357.9KSEC filing
  • 1,100 @ $109.57 · $120.53KSEC filing
  • 100 @ $110.04 · $11KSEC filing
DirectorCommon StockSale10b5-14 trades18,996avg $107.74 / share$2.05MSep 16Filed Sep 17 · 1d later
4 filings
  • 3,100 @ $106.13 · $329.01KSEC filing
  • 3,000 @ $106.83 · $320.48KSEC filing
  • 8,896 @ $108.04 · $961.12KSEC filing
  • 4,000 @ $108.99 · $435.96KSEC filing
PRESIDENT AND CEOCommon StockSale10b5-13 trades20,000avg $107.43 / share$2.15MSep 9Filed Sep 11 · 2d later
3 filings
  • 13,304 @ $107.22 · $1.43MSEC filing
  • 6,596 @ $107.82 · $711.19KSEC filing
  • 100 @ $108.67 · $10.87KSEC filing
PRESIDENT AND CEOCommon StockSale10b5-12 trades20,000avg $107.17 / share$2.14MSep 10Filed Sep 11 · 1d later
2 filings
  • 14,588 @ $107.01 · $1.56MSEC filing
  • 5,412 @ $107.58 · $582.23KSEC filing
PRESIDENT AND CEOCommon StockSale10b5-12 trades20,000avg $107.24 / share$2.14MSep 11Filed Sep 11 · 0d later
2 filings
  • 15,492 @ $107.15 · $1.66MSEC filing
  • 4,508 @ $107.55 · $484.83KSEC filing
PRESIDENT AND CEOCommon StockSale10b5-15 trades20,000avg $102.60 / share$2.05MAug 17Filed Aug 19 · 2d later
5 filings
  • 900 @ $98.96 · $89.06KSEC filing
  • 500 @ $100.46 · $50.23KSEC filing
  • 2,100 @ $101.77 · $213.71KSEC filing
  • 9,000 @ $102.55 · $922.98KSEC filing
  • 7,500 @ $103.48 · $776.12KSEC filing
PRESIDENT AND CEOCommon StockSale10b5-13 trades20,000avg $104.18 / share$2.08MAug 18Filed Aug 19 · 1d later
3 filings
  • 5,703 @ $103.08 · $587.88KSEC filing
  • 4,897 @ $104.11 · $509.83KSEC filing
  • 9,400 @ $104.87 · $985.82KSEC filing
PRESIDENT AND CEOCommon StockSale10b5-13 trades20,000avg $107.00 / share$2.14MAug 19Filed Aug 19 · 0d later
3 filings
  • 7,200 @ $106.36 · $765.78KSEC filing
  • 9,600 @ $107.22 · $1.03MSEC filing
  • 3,200 @ $107.77 · $344.85KSEC filing
DirectorCommon StockSale10b5-11,626$102.80 / share$167.15KAug 10Filed Aug 11 · 1d laterSEC filing
PRESIDENT AND CEOCommon StockSale10b5-12 trades1,923avg $79.77 / share$153.39KJul 8Filed Jul 9 · 1d later
2 filings
  • 888 @ $79.28 · $70.4KSEC filing
  • 1,035 @ $80.19 · $82.99KSEC filing
DirectorCommon StockSale10b5-12 trades1,625avg $76.71 / share$124.65KJul 1Filed Jul 2 · 1d later
2 filings
  • 1,000 @ $76.40 · $76.4KSEC filing
  • 625 @ $77.21 · $48.26KSEC filing
DirectorCommon StockSale10b5-17,304$75.00 / share$547.8KJun 29Filed Jun 30 · 1d laterSEC filing
PRESIDENT AND CEOCommon StockSale10b5-13 trades20,000avg $67.58 / share$1.35MJun 1Filed Jun 3 · 2d later
3 filings
  • 1,610 @ $66.39 · $106.88KSEC filing
  • 12,989 @ $67.41 · $875.59KSEC filing
  • 5,401 @ $68.35 · $369.14KSEC filing
PRESIDENT AND CEOCommon StockSale10b5-12 trades20,000avg $66.39 / share$1.33MJun 2Filed Jun 3 · 1d later
2 filings
  • 16,600 @ $66.31 · $1.1MSEC filing
  • 3,400 @ $66.75 · $226.93KSEC filing
PRESIDENT AND CEOCommon StockSale10b5-14 trades10,000avg $69.07 / share$690.65KJun 3Filed Jun 3 · 0d later
4 filings
  • 400 @ $66.37 · $26.55KSEC filing
  • 1,500 @ $67.68 · $101.51KSEC filing
  • 2,000 @ $68.74 · $137.47KSEC filing
  • 6,100 @ $69.69 · $425.12KSEC filing
DirectorCommon StockSale10b5-11,625$66.21 / share$107.59KJun 1Filed Jun 2 · 1d laterSEC filing
PRESIDENT AND CEOCommon StockSale10b5-13 trades20,000avg $65.35 / share$1.31MMay 11Filed May 13 · 2d later
3 filings
  • 9,725 @ $64.63 · $628.54KSEC filing
  • 3,575 @ $65.46 · $234.01KSEC filing
  • 6,700 @ $66.33 · $444.39KSEC filing
PRESIDENT AND CEOCommon StockSale10b5-15 trades20,000avg $71.75 / share$1.44MMay 12Filed May 13 · 1d later
5 filings
  • 100 @ $67.85 · $6.79KSEC filing
  • 1,398 @ $70.29 · $98.26KSEC filing
  • 9,802 @ $71.37 · $699.57KSEC filing
  • 5,900 @ $72.15 · $425.67KSEC filing
  • 2,800 @ $73.12 · $204.74KSEC filing
PRESIDENT AND CEOCommon StockSale10b5-14 trades10,000avg $69.19 / share$691.91KMay 13Filed May 13 · 0d later
4 filings
  • 2,100 @ $68.10 · $143.01KSEC filing
  • 3,350 @ $68.88 · $230.75KSEC filing
  • 3,950 @ $69.79 · $275.66KSEC filing
  • 600 @ $70.81 · $42.49KSEC filing
DirectorCommon StockSale10b5-11,625$63.48 / share$103.16KMay 1Filed May 5 · 4d laterSEC filing
PRESIDENT AND CEOCommon StockSale10b5-12 trades10,000avg $63.50 / share$634.98KApr 6Filed Apr 7 · 1d later
2 filings
  • 5,900 @ $63.14 · $372.52KSEC filing
  • 4,100 @ $64.02 · $262.46KSEC filing
PRESIDENT AND CEOCommon StockSale10b5-12 trades20,000avg $65.38 / share$1.31MApr 1Filed Apr 2 · 1d later
2 filings
  • 19,000 @ $65.36 · $1.24MSEC filing
  • 1,000 @ $65.71 · $65.71KSEC filing
PRESIDENT AND CEOCommon StockSale10b5-12 trades20,000avg $64.24 / share$1.28MApr 2Filed Apr 2 · 0d later
2 filings
  • 15,800 @ $64.06 · $1.01MSEC filing
  • 4,200 @ $64.89 · $272.53KSEC filing

Congress transactions 1

All Congress filings
Purchase disclosed

Halozyme Therapeutics, Inc. - Common Stock (HALO) · Stock

The filing reports a purchase for the member.

Gilbert Cisneros official portraitGilbert CisnerosReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
March 9, 2026
Filed April 7, 2026 · 29d laterOriginal report
Explore furtherTechnical lab Company financials Test a strategy Compare company

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage
Source
SEC EDGAR · Form 4
Issuer CIK
0001159036
Latest public acceptance
Oct 2, 2026, 08:43 PM UTC
Score calculated
Oct 8, 2026, 03:53 PM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.